Research Journal of Pharmacology and Pharmacodynamics

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Etiopathogenisis of Oral Sub Mucous Fibrosis


Affiliations
1 Mar Baselios Dental College, Kothamangalam, India
     

   Subscribe/Renew Journal


Oral sub mucous fibrosis is a premalignant condition mainly associated with the practice of chewing betel quid containing arecanut,a habit common among south Asian people. Commercially freeze dried products such as pan masala, gutka and mava have high concentration of areca nut per chew and appear to cause OSMF more rapidly than by self prepared conventional betel quid. It is characterized by inflammation, increased deposition of sub mucosal collagen mediated as a result of arecoline and formation of fibrotic bands in the oral and Para oral tissues, which increasingly limit the mouth opening. Currently the role of genetic susceptibility and that of autoimmunity are receiving attention. The aim of this paper was to discuss the etiopathogenesis of oral sub mucous fibrosis.

Keywords

Oral Sub Mucous Fibrosis, Etiology-Pathogenesis, Areca Nut, Precancerous Condition.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Pindborg J, Sirsat S, Oral sub mucous fibrosis. Oral surgery, oral medicine ,and oral pathology 1966;22(6):764.

  • Rajendran R .oral sub mucous fibrosis :etiology, pathogenesis, and future research. Bulletin of the world health organization 1944;72(6):985-96.

  • Phatak A. fibrin producing factor in oral sub mucous fibrosis Indian journal of otolaryngology and Head and neck surgery 1979;31(4):103-4.

  • Rajendran R, Sugathan C, Ramani P, Ankathil R, Vijaya Kumar T. cell mediated and humoral immune responses in oral sub mucous fibrosis. Cancer 1986;58(12):2628-31.

  • Canniff J, Harvey W, Harris M. oral sub fibrosis: its pathogenesis and management British dental journal 1986;160(12):429-34

  • Sinor p, Gupta P, Murti P, Bhonsle R, Dafffary D, Mehta F, Pndvorg J. a case control study of oral sub mucous fibrosis with special reference to the etiologic role of arecanut . Journalof oral pathology and medicine 1990; 19(12):94-8.

  • Auluck A, Rosin M. P, Zhang L, Sumanth K.N. oral sub mucous fibrosis , a clinically benign and potentially malignant disease:report of 3 cases and review of literature

  • Pillai R, Balram P, Reddiar K. S. pathogenesis of oral sub mucous fibrosis: relationship to risk factors associted with oral cancer 1992;69:2011-20.

  • K Kiran kumar, T.R Saraswathy, K Ranganadhan, M umadevi, Joshna elizabath.oral sub mucous fibrosis:a clinic ohistopathological study in chennai. IJDR 2007;18:106-111.

  • IARC Aconymous tobacco habits other than smoking :betel quid and arecanut chewing and some related nitrosamines. IARC Monogr Eval carcinog risk chem hum 1985;37:141-200.

  • MaRH, Tsaicc, Shieh TY. increased lysyl oxidise activity in fibroblast cultured from oral sub mucous fibrosis associated with betel nut chewing in Tainwan J oral pathol med 1995;24:407-12.

  • Hoffmann D, Rivenson A, Prokopczykd, Brunnemannk.D, Carmella SG, Hoffmanni. Advaces in tobacco carcinogenesis I. smokeless tobacco and betel quid in : Gupta PC, Hamlerje, Murti PR, eds. control of tobacco related cancers and other diseases. Bombay. Oxford University press 1992.pp.193-204.

  • Gupta PC et al. incidence rates of oral cancer and natural history of oral precancerous lesions in a 10 year follow up study of Indian villages .community dent. Oral epidemiol ,1980,8:287331.

  • Sinor PN, Gupta PC , Murti PR, et al .a case control study of oral sub mucous fibrosis with special reference to the Etiologic role of arecanut. J oral pathol med 1990;19:94-8.

  • Ahmad MS. Epidemiological and etiological study of oral submucous fibrosis among Gutkha chewers of Patna, Bihar, India. J Indian Soc pedod prev Dent –June 2006.84-89.

  • M.K Gupta oral submucous fibrosis-current concepts in Etiopathogenesis: people’s journal of scientific research:vol 1July 08:

  • Rajendran R. Oral submucousfibrosis: Etiology. pathogenesis and future research. Bull WHO 1994;72:985-96

  • Tilakaratone W. M, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. oral sub mucous fibrosis: Review on etiology and pathogenesis. Oral Oncol 2006;42(6):561-8.

  • Dyavanagoudar SN. Oral sub mucous fibrosis: review on etiopathogenesis. J cancer sci Ther 2009;1:72-7.

  • Rasika Pawiththra Illeperuma, Mi Heon Ryu, Kiyeol Kim W. M. Tilakaratne, Jin Kim (2010) relationship of fibrosis and the expression of TGFb1,MMP1 and TIMP-1 with epithelial dysplasia in oral sub mucous fibrosis. Oral Med Pathol 15:25-32

  • Yadav S, Verma A, Sachdeva A, Virdi MS. Etiopathogenesis and management of oral sub mucous fibrosis. The internet journal of bioengineering 2011;5(1):do I;10.5580/217.

  • Khan I, Kumar N, Pant I, Narra S, Kondaiah P(2012)activation of TGF pathway by areca nut constituents:a possible cause of oral sub mucous fibrosis.plos onet:e51806

  • Mountasian Karwan A, Jenel Veronika, Sapienza Karen, Marsh Daniel, Weinreb paul H.et al(2011)Betel derived alkaloid upregulates keratinocyte alpha beta 6 integrin expression and promotes oral sub mucous fibrosis journal of pathology 223:366377.

  • Rasika Pawiththra Illeperuma, Mi Heon Ryu, Kiyeol Kim W. M. Tilakaratne, Jin Kim (2010) relationship of fibrosis and the expression of TGFb1,MMP1 and TIMP-1 with epithelial dysplasia in oral sub mucous fibrosis. Oral Med Pathol 15:25-32.

  • Phatak AG. Fibrin producing factor in oral sub mucous fibrosis. Indian J orolaryngol 1979;31:103-4.

  • Phatak AG. Oral sub mucous fibrosis-a chronic disseminated intravascular coagulation syndrome with local coagulopathy. Gut 1993;33:713.

  • Tilakarne WM, Iqbal Z, Tech MT, Ariyawardana A, Pitiyage G, Cruchley A et al. regulation of HIF1a in malignant transformation of oral submucous fibrosis. Joralpathol med2008;37: 375-7

  • Sabarinath B, Sriram G, Saraswathi TR, Sivapathasundharan B. Immunohistochemical evaluation of mast cells and vascular endothelial proliferation in oral sub mucous fibrosis. Indian J Dent Res 2011;22:116-21.

  • Jalouli J, Ibrahim SO, Mehrotra R, Jalouli M. M, Sapkota D,Larssan P.A et al. prevalence of viral infections in oral sub mucous fibrosis and oral cancer from India. Acta Otolaryngol 2010;130(11):1306-11

  • Rajendran R, Rajev R, Anil S, Alasquah M, Rabi AG. Helicobacter pylori coinfection is a confounder ,modulating mucosal inflammation in OSMF, Indian J Dent Res 2009;2012:206-11.

  • Ariyawardana A, Panagoda GJ, Fernado HN, EllepolaAN, Tilakaratne WM, Samaranayake LP et al.oral sub mucous fibrosis and oral yeast carriage-a case controle study in srilankan patients mycoses.2007;50(2):116-20.

  • Mithani SK, Mydiarz WK, Grumbine FL, Smith IM, Califano JA(2007) molecular genetics of premalignant oral lesions.oral dis 13:126-133.

  • Canniff JP, Harvey W, Harris M, Oral sub mucous fibrosis :its pathogenesis and management.Br Dent J 1986:160:429-34.

  • HUY, Jian X, Peng J, Jiang X, LiN, et al(2008) gene expression profiling of oral sub mucous fibrosis using aligo nocleotide microarray. Oncol Rep 20:287-294.

  • Lee PH, Chang MC, Chang WH, Wang TM, Wang YJ et al (2006)prolonged exposure to arecoline arrested human KB epithelial cell growth, regulatory mechanisms of cell cycle and apoptosis. Toxicology 220:81-89.

  • Cannif JP, Harvey W, Harris Moral submucous fibrosis: reprint requests to: pathogenesis and management.Br Dent J 1986;160:429-34.

  • Kallenbberg CGM, Van Der Voort-Beelen JM, D’amaroj THE TH.scleroderma:increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response. Clin Exp Immunol 1981:43:475-85.

  • Whiteside TL, Medsger TA, JR, Rodnan GP,Hla DR antigens in progressive systemic sclerosis.J Rheumatol 1983:10:163-7.

  • Chiang CP, Hsieh RP, Chen THH, Chang YF, Liu BY, Wang JT, et al. High incidence of autoantibodies in Taiwanese patients with oral sub mucous fibrosis. J oral pathol med 2002;31:402-9.

  • Sulthana N, Pallagatti S, Mohammed Al.p53 expressions in oral sub mucous fibrosis and oral cancer. International journal of oral and maxillofacial pathology;2011:2(1):9-14.

  • Liao PH, Lee TL, Yang LC, Yang SH, Chen SL, Chen MY, Adenomatous poliposis coli gene mutation and decreased wild type p53 protein expression in oral sub mucous fibrosis:a peliminary investigation. Oral Surg Oral Med Oral Pathol oral Radiol Endol.2001;92(2):202-7.

  • Rajendran R, Sughathan CK, Remani P, Aukathil R, Vijayakumar T cell mediated and humoral immune responses in OSMF. cancer 1986;58(12):2628-31.

  • VargheseI, Sugathan CK, Balasubramoniyam G, Vijayakumar T .serum copper and zinc levels in premalignant and malignant lesions of the oral cavity. Oncol 1987:44:224-7.

  • Sonali K, Freny K, Immunological and biochemical markers in oral precancer and cancer ;A study .JIAOMR 2005;17(4):161

  • Khanna Sunali S, Karjodkar Freny R. Circulating immune complexes and trace elements (copper, iron, and selenium) as markers in oral precancer and cancer. A randomized controlled clinical trial. Head face med 2006;2:33.

  • Anila K, Kaveri H, Naikmasur VG. Comparative study of oral micronucleated cell frequency in oral sub mucous fibrosis patients and healthy individuals. J Chin Exp Dent 2011;3(3);e 201-6.

  • Holland N, Bolognesi C, Kirsch-volders M. Bonassi S, Knasmueller S, et al. The micronucleus assay in human buccal cells as a tool for biomonitoring DNA damage :the Human project perspective on current status and knowledge gaps. Mutat Res 2008; 659:93-108.

  • Sun, Yi. (1990)Free radicals antioxidant enzymes and carcinogenesis. Free radical Biol .Med.8,583-599.

  • Freeman, B.A, and Crapo ,J.D(1982) free radicals and tissue injury .Lab.47,412-425.


Abstract Views: 236

PDF Views: 0




  • Etiopathogenisis of Oral Sub Mucous Fibrosis

Abstract Views: 236  |  PDF Views: 0

Authors

Anju Mary Daniel
Mar Baselios Dental College, Kothamangalam, India
Eby Aluckal
Mar Baselios Dental College, Kothamangalam, India
Giju Baby George
Mar Baselios Dental College, Kothamangalam, India
Mathews Baby
Mar Baselios Dental College, Kothamangalam, India

Abstract


Oral sub mucous fibrosis is a premalignant condition mainly associated with the practice of chewing betel quid containing arecanut,a habit common among south Asian people. Commercially freeze dried products such as pan masala, gutka and mava have high concentration of areca nut per chew and appear to cause OSMF more rapidly than by self prepared conventional betel quid. It is characterized by inflammation, increased deposition of sub mucosal collagen mediated as a result of arecoline and formation of fibrotic bands in the oral and Para oral tissues, which increasingly limit the mouth opening. Currently the role of genetic susceptibility and that of autoimmunity are receiving attention. The aim of this paper was to discuss the etiopathogenesis of oral sub mucous fibrosis.

Keywords


Oral Sub Mucous Fibrosis, Etiology-Pathogenesis, Areca Nut, Precancerous Condition.

References